目前的进展和口服生物可用PROTACs的开发策略
Shenxin Zeng1, Yingqiao Ye1, Heye Xia1
1Affiliated Yongkang First People's Hospital and School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang, 311399, China; School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang, 311399, China; Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, School of Pharmacy, Hangzhou Medical College, Hangzhou, Zhejiang, 311399, China; Key Discipline of Zhejiang Province in Public Health and Preventive Medicine (First Class, Category A), Hangzhou Medical College, China.
由于其复杂的结构,开发口服生物可用蛋白质分解向化马体 (PROTACs) 是具有挑战性的. 本综述强调了创建口服可用的PROTACs的策略,重点关注药物化学和药物动力学特性.
科学领域:
- 药物的发现和开发.
- 药品化学 药品化学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对蛋白质分解的嵌合体 (PROTACs) 提供了超越传统药物的扩大治疗潜力.
- 几种PROTAC已经进入临床试验阶段,显示出重大研究兴趣.
- PROTACs经常超过"五项规则",这给口服生物利用性带来了挑战.
结论:
- 最近在开发口服生物可利用的PROTAC方面取得了进展.
- 本综述为口腔PROTAC开发提供了全面的策略.
- 总结的方法可以指导未来的研究口腔PROTACs.
相关概念视频
Prodrugs
Prodrugs help overcome...
Drug Biotransformation: Overview
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...


